WPRIM Management System> DCMS> Chinese Journal of Clinical Oncology> 2016> 43

Volume: 43

1. Research progress on PI3K/AKT/mTOR signal pathway in lymphoma Page:211—215
2. Clinical observation on oxaliplatin reintroduction combined with raltitrexed as second-line chemotherapy after the first-line oxaliplatin-based chemotherapy in advanced colorectal cancer patients Page:188—193
3. Mechanisms of tumor invasion metastasis caused by long-term anti-angiogenic therapy Page:310—313
4. Clinical features and prognosis of pinealoblastoma in children Page:298—301
5. Effect of protein tyrosine phosphatase non-receptor type 12 (PTPN12) downregulation on the radiosensitivity of non-small cell lung cancer Page:285—290
6. Efficacy of cytokine-induced killer cells on patients with advanced lung cancer Page:302—305
7. Correlation of Ki-67 expression with MRS metabolism in low-and high-grade cerebral gliomas Page:281—284
8. Expression and clinical significance of AOC4P in hepatocellular carcinoma Page:344—347
9. Implantation of intrathecal infusion system for intractable cancer pain therapy Page:339—343
10. Analysis of prognostic factors and the related factors on subtype transformation of ret-roperitoneal liposarcoma Page:334—338
11. Expression of Shank1 and its clinical significance in renal cancer tissue Page:329—333
12. Research progress on Sprouty protein in tumor Page:358—360
13. Research progress in multiple regulation pathways of STAT3 in cancer Page:352—357
14. Mechanism of transcription factors KLFs in the occurrence and development of HCC Page:348—351
15. Influence of stem-like cells on EMT occurrence in mice with triple-negative breast can-cer and on their biological behavior Page:324—328
16. Progress on diagnosis and treatment of histiocytic cell sarcoma Page:220—222
17. Advances and the current status in chemotherapy-free management for indolent lym-phomas Page:216—219
18. Clinical significance of the application of thromboelastogram in the perioperative peri-od of gastric cancer patients Page:199—203
19. Dose titration of transdermal fentanyl patches with fentanyl administrated by patient-controlled intravenous analgesia for cancer-related pain of opioid-naive patients Page:194—198
20. Analysis of clinicopathological factors for node-negative colon cancer patients with synchronous liver metastases Page:183—187
21. Advances in therapeutic options of peripheral T-cell lymphoma Page:166—169
22. Advances in functions and mechanisms of long non-coding RNA MALAT-1 in tumors Page:161—165
23. Treatment of synchronous peritoneal carcinomatosis from gastric cancer with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy with lobaplatin and docetaxel Page:146—151
24. Mechanism of anticoagulation therapy for non-small cell lung cancer Page:173—176
25. Research progress on molecular targeted therapy for metastatic esophageal cancer pa-tients Page:170—172
26. A comparative study of 18F-FDG PET/CT and CT in the early evaluation of response to chemotherapy in patients with non-small cell lung cancer Page:156—160
27. Efficacy of S-1 combined with cisplatin as first-line chemotherapy for advanced AFP positive gastric cancer Page:152—155
28. Using next-generation sequencing technology to evaluate biomarkers associated with anti-EGFR efficacy in metastatic colorectal cancer Page:141—145
29. Nimotuzumab enhanced the radio sensitivity of esophageal squamous cell carcinoma Page:135—140
30. Therapeutic strategy for HER-2-positive advanced breast cancer Page:412—417
31. Molecular imaging and tumor targeted therapy Page:475—479
32. Diagnosis and minimally invasive treatment of adrenal tumors Page:471—474
33. Minimally invasive technique for potential application in colorectal cancer surgery Page:464—466
34. Research progress on the circadian clock gene PER in tumors Page:446—450
35. Progress on exosomal transmission of microRNAs in cancer research Page:442—445
36. Adverse reactions of chemoradiotherapy with docetaxel after modified radical mastectomy in locally advanced breast cancer Page:438—441
37. Consistency analysis of gastric cancer HER-2 expression among endoscopic biopsy and radical operation specimens Page:429—431
38. Clinicopathological characterization of 1,058 cases with primary esophageal benign tu-mor in China Page:424—428
39. Advances in chemotherapy of small cell lung cancer Page:418—423
40. Progress on metastasis induced by myeloid-derived suppressor cells to promote circu-lating tumor cell Page:493—497
41. Clinical analysis of Hyper-CVAD/MA regimen and CHOP/CHOP-like regimen in the treatment of 78 patients with peripheral T-cell lymphoma, not otherwise specified (PT-CL-NOS) Page:486—492
42. Correlation analysis of indolent B-cell non-Hodgkin lymphoma and hepatitis virus Page:480—485
43. Minimally invasive and precise treatment of malignant tumor Page:452—456
44. Value of magnetic resonance imaging-guided minimally invasive treatment in glioma and its metastatic tumor Page:467—470
45. Advances on interventional molecular imaging Page:457—463
46. Pathological complete response of locally advanced gastric cancer after neoadjuvant chemotherapy:a report of five cases and a literature review Page:265—270
47. Clinical characteristics of 15 glioma cases with leptomeninges and spinal cord metastases Page:260—264
48. Characteristics and prognosis of EBV-positive gastric diffuse large B-cell lymphoma Page:255—259
49. Analysis and prevention of postoperative delayed hemorrhage associated with radical D2 gastrectomy Page:245—249
50. Clinical analysis of postoperative radiotherapy in type B3 thymoma patients Page:240—244
51. Clinical comparative study of oncoplastic and standard breast-conserving surgery in the treatment of early breast cancer Page:235—239
52. Expression of miR-92a in colorectal cancer and its effect on tumor angiogenesis Page:223—227
53. Research progress on STMN1 and gastric cancer Page:392—395
54. Changes of circulating tumor cells in locally advanced esophageal squamous cell carci-noma patients treated with concurrent chemoradiotherapy Page:381—384
55. Prospective cohort study on the value of high-risk human papillomavirus viral load and subtype tests in predicting cervical intraepithelial neoplasia Page:376—380
56. Perioperative therapy for patients with locally advanced esophageal cancer Page:511—515
57. The current status and perspectives of esophagectomy Page:507—510
58. The role of a multidisciplinary team in diagnosing and treating esophageal cancer Page:502—506
59. Molecular basis and precision medicine for interactions of genetic and environmental risk factors in esophageal cancer Page:515—520
60. Clinical research advances of apatinib in the treatment of malignancies Page:545—548
61. Research progress on integrated molecular pathological classification of diffuse lower-grade gliomas Page:541—544
62. Research progress on clinical pathology for double-hit diffuse large B-cell lymphoma Page:536—540
63. Epidermal growth factor receptor mutations in primary tumors, N2 lymph nodes, and plasma samples in Chinese patients with stageⅢA-N2 non-small cell lung cancer Page:531—535
64. Research progress on radiotherapy of esophageal carcinoma Page:527—530
65. Analysis of the clinical characteristics and treatment of 494 cases of esophageal adeno-squamous carcinoma Page:521—526
66. Clinical effects of different surgical methods on papillary carcinoma of the thyroid with clinically negative lymph nodes Page:366—370
67. Blockade of CLC-3 chloride channel inhibited the viability and invasion of colorectal cancer cells Page:361—365
68. Research progress on the influence of anti-angiogenetic agents on antitumor immuni-ty regulation Page:400—403
69. Signaling pathways related to multidrug resistance in epithelial ovarian cancer Page:396—399
70. Clinical decision on a patient with ALK+diffuse large B cell lymphoma Page:385—391
71. Efficacy of percutaneous vertebroplasty with radiotherapy for bone metastasis pain Page:371—375
72. Advances in diagnosis and treatment of small bowel adenocarcinoma Page:585—588
73. Correlation of 3D ASL perfusion index with the expression of VEGF and MVD in glioma Page:557—561
74. Analyses of the clinical and pathological features of follicular thyroid carcinoma with distant metastasis as first manifestation Page:552—556
75. Application of the PD-1 antibody in melanoma therapy Page:589—592
76. Advances of TGF-β-induced long non-coding RNAs in tumors Page:581—584
77. Investigation progress of molecular biomarkers from body fluids in early gastric cancer Page:577—580
78. Analysis of the clinical and epidemiological changes, treatments, and prognoses of pri-mary esophageal small cell carcinoma Page:571—576
79. Risk factors of microinvasion in breast ductal carcinoma in situ Page:567—570
80. Serum microRNA profiles as novel biomarkers for the post-operative evaluation and survival of patients with glioblastoma multiform Page:562—566
81. Assessment of EBV antibodies and EBV-DNA in the diagnosis and stages of nasopha-ryngeal carcinoma Page:650—654
82. Reconsidering the use of neoadjuvant chemotherapy in breast cancer Page:643—645
83. Analysis of diabetes mellitus increasing the risk of intravesical recurrence in patients with upper urinary tract urothelial carcinoma after radical nephroureterectomy Page:663—667
84. Clinical analysis of 40 patients with multiple primary carcinomas using multidisci-plinary consultation for palliative treatment Page:674—678
85. Influence of preoperative antiviral therapy on HBV reactivation and liver function after liver resection in HBV-DNA-negative hepatocellular carcinoma patients Page:668—673
86. Expression of long non-coding RNA MEG3 and its relationship with the prognosis of human gastric cancer Page:659—662
87. The use of European Organization of Research and Treatment of Cancer Risk Tables to predict the prognosis of patients with T1 non-muscle-invasive bladder cancer Page:655—658
88. Measurement of serum heavy/light chain in monoclonal plasma cell proliferative disor-ders Page:646—649
89. Research progress on clinical transformation and staging of lymph node in gastric cancer Page:683—689
90. Research progress on anticancer therapeutics targeting telomere/telomerase Page:679—682
91. Perspective on B-cell lymphoma treatment Page:607—612
92. Diagnosis and treatment of extranodal NK/T-cell lymphoma, nasal type Page:603—606
93. Progression of Bruton tyrosine kinase (BTK) inhibitor in B-cell lymphoma Page:598—602
94. Advances in research on population-based female breast cancer survival in China Page:639—642
95. Prognostic impact of different analgesics after colorectal surgery Page:635—638
96. Multidisciplinary treatment for a patient with multiple cranial nerve involvement of plasmablastic myeloma Page:631—634
97. Clinical study on sequential platinum regimen as primary therapy for young patients with diffuse large B-cell lymphoma Page:626—630
98. Retrospective analysis of the clinical features and prognostic factors of 126 patients with primary gastric diffuse large B-cell lymphoma Page:620—625
99. Advances and Updates on pathological diagnosis of lymphoma Page:613—619
100. Research progress and prognostic significance of EZH2 in acute myeloid leukemia Page:727—730
101. Concurrent raltitrexed plus oxaliplatin and radiotherapy versus PF synchronous radio-therapy on advanced esophageal cancer Page:718—722
102. Differential proteomic study of papillary thyroid carcinoma and thyroid borderline lesion Page:712—717
103. Analysis of clinical and physical factors for acute bone marrow suppression induced by concurrent chemoradiotherapy in rectal cancer Page:707—711
104. miR-497 regulates cell proliferation and apoptosis by targeting Bcl-2 in liver cancer cells Page:697—701
105. Current status of photodynamic therapy for unresectable hilar cholangiocarcinoma Page:735—738
106. Research progress on HOTAIR in tumor biological behaviors Page:731—734
107. Ultrasound-guided percutaneous nephrostomy for the treatment of cancer-related hy-dronephrosis:a report of 289 cases Page:723—726
108. miR-143 suppresses the proliferation and migration of SGC7901 gastric cancer cells Page:702—706
109. Research progress on the application of immune checkpoint inhibitors in malignant lymphomas Page:922—926
110. Clinical observation of Capecitabine versus S-1 as maintenance therapy for advanced gastric cancer after the first-line inductive chemotherapy Page:913—917
111. Comparison study of efficacy evaluation based on RECIST 1.1 and mRECIST in hepato-cellular carcinoma treated with SBRT Page:902—906
112. Intensity modulated radiation therapy for primary liver cancer with portal vein/inferi-or vena cava tumor thrombosis Page:898—901
113. Effects of XBP1 on glioma cell viability and glycolysis under hypoxia Page:892—897
114. Research progress on patient-derived xenograft models of lung cancer Page:887—891
115. Progress on the diagnosis, treatment, and family management of Lynch syndrome Page:883—886
116. Hot issues in surgical treatment of early stage breast cancer patients in the era of preci-sion medicine Page:879—883
117. Predictive value of continuous and significant reduction of serum CEA and CA153 for non-imaging progression in patients with advanced breast cancer Page:865—868
118. Research progress on dignity therapy in patients with advanced cancer Page:873—876
119. Research progress on the relationship between the level of EBV antibodies and the tu-mor stages of nasopharyngeal carcinoma Page:869—872
120. Expression and clinical significance of CXCL14 and EGFR in human gastric cancer Page:860—864
121. Regulation of metastatic cervical lymph nodes in 428 cases of nasopharyngeal carcino-ma:metastasis distribution of posterior to level V Page:855—859
122. Efficacy comparison of different clinical target volume margins in the radical therapy of esophageal squamous cell carcinoma Page:849—854
123. Association of serum PGE-2 and VEGF levels and the expression of VEGF in gastric can-cer tissue and clinicopathological features of gastric carcinoma patients with hyperlip-idemia Page:845—848
124. Bioinformatics analysis of genes related to the progress of cervical intraepithelial neoplasia Page:840—844
125. Advances in the diagnosis and treatment of mantle cell lymphoma Page:835—839
126. Research progress on Rad51C in DNA damage repair Page:830—833
127. Clinical significance of microrna-625 expression in esophageal squamous cell carcino-ma Page:825—829
128. Effect of family history of cancer on clinical features and prognostic factors of patients with nasopharyngeal carcinoma Page:814—819
129. Fresh fruit consumption may decrease the long-term risk of acquiring esophageal cancer Page:808—813
130. DKK1 promotes linearly patterned programmed cell necrosis and vasculogenic mimic-ry in non-small cell lung cancer Page:797—803
131. Comparison and treatment of left-and right-side colon cancer Page:787—791
132. Research progress on the relationship between KPNA2 and tumors Page:780—784
133. Research progress of microRNA-29 in tumors Page:775—779
134. Twist regulation of EMT and its clinical significance in monitoring circulating tumor cells and evaluating effects of anticancer drugs Page:770—774
135. Treatment progress on castration-resistant prostate cancer Page:766—769
136. Clinical value of combining indocyanine green fluorescence navigation with blue dye in sentinel lymph node biopsy in patients with breast cancer Page:757—760
137. Clinical research on temozolomide chemotherapy for adult diffuse low-grade gliomas Page:753—756
138. Efficacy of neoadjuvant chemotherapy combined with postoperative adjuvant concur-rent radiotherapy and chemotherapy for stageⅢadvanced gastric cancer Page:747—752
139. Exploration Study of the osteosarcoma devitalization technique by vacuum dehydra-tion at room temperature Page:741—746
140. Theories and clinical applications of biochemotherapy for malignant carcinomas Page:1061—1066
141. Advances in medical prevention of breast cancer Page:1058—1060
142. Research progress on immunotherapy of nasopharyngeal carcinoma Page:1053—1057
143. Clinical efficacy of bevacizumab for the treatment of serious peritumorous brain edema Page:1045—1048
144. Ultrasound elasticity imaging correction and biopsy diagnosis value in BI-RADS 4 breast mass Page:1031—1034
145. Characteristics of stem cell spheres of the renal carcinoma cell lines SN12C and 786-O grown in serum-free culture medium Page:1021—1025
146. Clinical analysis of early death in multiple myeloma Page:1040—1044
147. Advances in immunotherapy for small cell lung cancer Page:1106—1111
148. Clinical efficacy of EGFR-TKIs for advanced squamous-cell lung cancer patients with EGFR mutations Page:1103—1105
149. Correlation of HPV types with Th17 and Treg cells in cervical cancer Page:1099—1102
150. Opportunities of precision medicine for triple-negative breast cancer Page:1074—1077
151. A clinical study of the characteristics of the cervical lymph node metastasis in patients with salivary gland adenoid cystic carcinoma Page:1094—1098
152. Role and mechanisms ofω-3 polyunsaturated fatty acids in inducing cell apoptosis and reversing drug resistance in multiple myeloma Page:1088—1093
153. Expression of GTPBP4 in hepatocelluar carcinoma (HCC) tissues and preliminary study on the functions of the GTPBP4 gene Page:1083—1087
154. Advances in the precision treatment of colorectal liver metastases Page:1078—1082
155. Hematopoietic stem cell transplantation:everyone has a donor Page:1069—1074
156. Imatinib mesylate therapy for patients with chronic myeloid leukemia:long-term out-come from a single center in China Page:432—437
157. Clinical efficacy of extended hepatectomy for types III and IV hilar cholangiocarcinoma Page:250—254
158. The analysis of clinical features of 140 cases with primary hyperparathyroidism Page:1035—1039

©2019 - Present World Health Organization Regional Office for the Western Pacific. All Rights Reserved.